Effects of estrogen on tight junctional resistance in cultured human umbilical vein endothelial cells.
OBJECTIVE
To study the effects of estrogen on transendothelial paracellular permeability in women.


METHODS
Human umbilical vein endothelial cells (HUVEC) obtained from women were grown on filters. The paracellular permeability characteristics were determined in terms of changes in the permeability to the polar acid pyranine (Ppyr) and as changes in the transendothelial electrical resistance (RTE). Tight junctional resistance characteristics were assayed by lowering luminal NaCl and measuring the dilution potential, and were expressed as the ratio of monoion mobility uCl/uNa (cation selectivity).


RESULTS
Low extracellular calcium and hyperosmolarity increased Ppyr and decreased RTE. The former but not the latter condition abolished the endothelium-specific cation selectivity. Treatment with 10 nM of estradiol-17 beta had no effect on RTE, but it increased the cation selectivity. The effect of estradiol required 1-6 hours' incubation with the hormone; it was dose dependent and saturable, with a median effective concentration of estradiol of 1 nM. Diethylstilbestrol, but not estriol, could mimic the effect of estradiol, and the estrogen receptor antagonist ICI-182, 780 blocked it.


CONCLUSIONS
Cultured HUVEC cells form patent tight junctions. Estrogens increase the cation selectivity across HUVEC cultures. The effect of estrogen may be mediated by an estrogen receptor. These effects may be important for vasculoprotection in cases of sudden changes in ions levels across the capillary wall, such as ischemia or reperfusion.
Cho
M M
MM
Department of Reproductive Biology, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Ziats
N P
NP
Abdul-Karim
F W
FW
Pal
D
D
Goldfarb
J
J
Utian
W H
WH
Gorodeski
G I
GI
D002118:Calcium / Q000008:administration & dosage; D002412:Cations; D002463:Cell Membrane Permeability; D002478:Cells, Cultured; D002712:Chlorides / Q000378:metabolism; D004054:Diethylstilbestrol / Q000494:pharmacology; D017097:Electric Impedance; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology / Q000648:ultrastructure*; D004958:Estradiol / Q000008:administration & dosage / Q000031:analogs & derivatives / Q000494:pharmacology*; D004965:Estrogen Antagonists / Q000494:pharmacology; D005260:Female; D000077267:Fulvestrant; D006801:Humans; D007700:Kinetics; D009994:Osmolar Concentration; D011247:Pregnancy; D012964:Sodium / Q000378:metabolism; D019108:Tight Junctions / Q000187:drug effects* / Q000502:physiology; D014471:Umbilical Veins
D002412:Cations; D002712:Chlorides; D004965:Estrogen Antagonists; D000077267:Fulvestrant; D004958:Estradiol; D004054:Diethylstilbestrol; D012964:Sodium; D002118:Calcium